sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate

Independent reference data for sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate (CAS 56767-76-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Compounds capable of relieving pain without the loss of CONSCIOUSNESS.Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Synonyms and trade names

FLURBIPROFEN SODIUM; 56767-76-1; M3QE6AS001; Flurbiprofen sodium anhydrous; 2-Fluoro-alpha-methyl-4-diphenylacetic acid sodium salt; DTXSID80972216; Z5B97MU9K4; Occufen; RefChem:55219; DTXCID301399697; Flurbiprofen sodium dihydrate; Ocufen; sodium;2-(3-fluoro-4-phenylphenyl)propanoate; Flurbiprofen sodium [USP]; Sodium flurbiprofen; Flurbiprofen sodium salt

GHS hazard classification

Reported hazard statements	H302 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

What the public record says

sodium 2-fluoro-α-methyl[1,1'-biphenyl]-4-acetate · CAS 56767-76-1 · C15H12FNaO2. UNII M3QE6AS001.

Source: PubChem / Wikidata; the batch COA governs where values differ.